Published on in Vol 6, No 3 (2022): March

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/29154, first published .
A Smartphone-Based Intervention as an Adjunct to Standard-of-Care Treatment for Schizophrenia: Randomized Controlled Trial

A Smartphone-Based Intervention as an Adjunct to Standard-of-Care Treatment for Schizophrenia: Randomized Controlled Trial

A Smartphone-Based Intervention as an Adjunct to Standard-of-Care Treatment for Schizophrenia: Randomized Controlled Trial

Journals

  1. Sverdlov O, Ryeznik Y. Accounting for Patient Engagement in Randomized Controlled Trials Evaluating Digital Cognitive Behavioral Therapies. Applied Sciences 2022;12(10):4952 View
  2. Torous J, Stern A, Bourgeois F. Regulatory considerations to keep pace with innovation in digital health products. npj Digital Medicine 2022;5(1) View
  3. Kwon S, Firth J, Joshi D, Torous J. Accessibility and availability of smartphone apps for schizophrenia. Schizophrenia 2022;8(1) View
  4. Torous J. A path towards progress: lessons from the hard things about digital mental health. World Psychiatry 2022;21(3):419 View
  5. Oh E, Gang M. Effect of Digital Health Interventions on Psychotic Symptoms among Persons with Severe Mental Illness in Community: A Systematic Review and Meta-Analysis. Journal of Korean Academy of Nursing 2023;53(1):69 View
  6. Blease C. Out of Control: How to Design Digital Placebos. Current Treatment Options in Psychiatry 2023;10(3):109 View
  7. Romagnoli A, Valentino F, Zovi A, Caprodossi A, Vitiello A, Ferrara F. The Development of Digital Therapies as a New Therapeutic Option to Treat Diseases: Focus on the International Regulatory Framework. Journal of Pharmaceutical Innovation 2023;18(4):2447 View
  8. Macrynikola N, Nguyen N, Lane E, Yen S, Torous J. The Digital Clinic: An Innovative Mental Health Care Delivery Model Utilizing Hybrid Synchronous and Asynchronous Treatment. NEJM Catalyst 2023;4(9) View
  9. Chang S, Alon N, Torous J. An exploratory analysis of the effect size of the mobile mental health Application, mindLAMP. DIGITAL HEALTH 2023;9 View
  10. Grasa E, Seppälä J, Alonso-Solis A, Haapea M, Isohanni M, Miettunen J, Caro Mendivelso J, Almazan C, Rubinstein K, Caspi A, Unoka Z, Farkas K, Usall J, Ochoa S, van der Graaf S, Jewell C, Triantafillou A, Stevens M, Reixach E, Berdun J, Corripio I. m-RESIST, a Mobile Therapeutic Intervention for Treatment-Resistant Schizophrenia: Feasibility, Acceptability, and Usability Study. JMIR Formative Research 2023;7:e46179 View
  11. Goldberg S, Sun S, Carlbring P, Torous J. Selecting and describing control conditions in mobile health randomized controlled trials: a proposed typology. npj Digital Medicine 2023;6(1) View
  12. Chukka A, Choudhary S, Dutt S, Bondre A, Reddy P, Tugnawat D, Rozatkar A, Mehta U, Manjunatha N, Keshavan M, Patel V, Math S, Kumar C, Thirthalli J, Bhan A, Torous J, Naslund J. Digital Interventions for Relapse Prevention, Illness Self-Management, and Health Promotion In Schizophrenia: Recent Advances, Continued Challenges, and Future Opportunities. Current Treatment Options in Psychiatry 2023;10(4):346 View
  13. Fuhrmann L, Weisel K, Harrer M, Kulke J, Baumeister H, Cuijpers P, Ebert D, Berking M. Additive effects of adjunctive app-based interventions for mental disorders - A systematic review and meta-analysis of randomised controlled trials. Internet Interventions 2024;35:100703 View
  14. Kim S, Baek S, Cho C. Psychosocial and digital intervention for patients with schizophrenia. Journal of the Korean Medical Association 2024;67(2):103 View